Literature DB >> 18468868

Nature and course of cognitive function in late-life schizophrenia: a systematic review.

Tarek K Rajji1, Benoit H Mulsant.   

Abstract

OBJECTIVES: To systematically review the literature on the nature and course of cognition in late-life schizophrenia (LLS).
METHODS: We conducted a literature search using Medline. Search terms included schizophrenia, cognition, memory, and other cognitive search terms. We limited our search to age 45 and above. All titles or abstracts were read, and relevant papers were reviewed. Only cross-sectional studies with healthy control groups or longitudinal studies of cognition in LLS are presented in this review.
RESULTS: We identified 23 publications reporting on cross-sectional studies comparing cognition in subjects with LLS and healthy controls, and 19 publications reporting on cognitive changes during longitudinal follow-up. The cross-sectional reports suggest that patients with LLS are most consistently impaired in executive function, visuospatial ability, and verbal fluency. Impairment has less consistently been observed in memory, attention, and working memory. Longitudinal studies suggest that patients with LLS start to decline cognitively around the age of 65, and that this decline may first affect visuospatial abilities. However, most of these studies have been conducted in institutionalized patients, rather than the typical ambulatory population. Other limitations include small sample sizes, short follow-up periods, and lack of comprehensive neuropsychological assessments.
CONCLUSIONS: The existing literature suggests that the nature and course of cognition in LLS is heterogeneous. Larger and longer studies using both comprehensive and specific cognitive assessments are needed to understand the causes and consequences of this heterogeneity.

Entities:  

Mesh:

Year:  2008        PMID: 18468868     DOI: 10.1016/j.schres.2008.03.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

1.  Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.

Authors:  T H Zhang; H J Li; K A Woodberry; L H Xu; Y Y Tang; Q Guo; H R Cui; X H Liu; A Chow; C B Li; K D Jiang; Z P Xiao; L J Seidman; J J Wang
Journal:  Epidemiol Psychiatr Sci       Date:  2016-04-08       Impact factor: 6.892

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

Review 3.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

4.  Computerized neurocognitive test performance in schizophrenia: a lifespan analysis.

Authors:  Farzin Irani; Colleen M Brensinger; Jan Richard; Monica E Calkins; Paul J Moberg; Waren Bilker; Raquel E Gur; Ruben C Gur
Journal:  Am J Geriatr Psychiatry       Date:  2012-01       Impact factor: 4.105

5.  Empirically defined patterns of executive function deficits in schizophrenia and their relation to everyday functioning: a person-centered approach.

Authors:  Mary Iampietro; Tania Giovannetti; Deborah A G Drabick; Rachel K Kessler
Journal:  Clin Neuropsychol       Date:  2012-10-04       Impact factor: 3.535

6.  Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Y Zhang; Da C Chen; Mei H Xiu; Fu D Yang; Yunlong Tan; Xingguang Luo; Lingjun Zuo; Therese A Kosten; Thomas R Kosten
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

Review 7.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

8.  Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.

Authors:  Christina Ting; Tarek K Rajji; Zahinoor Ismail; David F Tang-Wai; Nina Apanasiewicz; Dielle Miranda; David Mamo; Benoit H Mulsant
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

9.  Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders.

Authors:  Josephine Mollon; Samuel R Mathias; Emma E M Knowles; Amanda Rodrigue; Marinka M G Koenis; Godfrey D Pearlson; Abraham Reichenberg; Jennifer Barrett; Dominique Denbow; Katrina Aberizk; Molly Zatony; Russell A Poldrack; John Blangero; David C Glahn
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

10.  Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery.

Authors:  Tarek K Rajji; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Tamara Arenovich; Mahesh Menon; Zahinoor Ismail; Robert S Kern; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-22       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.